Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ABUSASND

Arbutus Biopharma Corp

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ABUS

78/100

ASND

73/100

Quality

Is it a profitable, well-run business?

ABUS

10.0/10

ASND

6.5/10

Growth

Is the company growing?

ABUS

8.0/10

ASND

9.7/10

Valuation

Is the price reasonable? (higher = cheaper)

ABUS

7.5/10

ASND

4.6/10

Risk

How risky are the shares? (higher = lower risk)

ABUS

7.3/10

ASND

8.1/10

Momentum

Is the share price trending up?

ABUS

5.5/10

ASND

9.4/10

Financial strength

Is the balance sheet healthy?

ABUS

9.0/10

ASND

7.1/10

The balanced view

Model-generated

Arbutus Biopharma Corp

This company scores well across most areas, with strong profitability and supportive analyst views.

Leads on: quality, valuation, financial strength

Best feature: strong profitability (Return on equity (TTM): 91.0%)

Watch out: weakest area: price momentum (Signal consensus: Strong Sell)

Ascendis Pharma A/S

This company scores above average, with solid growth and a positive price trend.

Leads on: growth, risk, momentum

Best feature: solid growth (Revenue growth (FY): 90.2%)

Watch out: weakest area: valuation (EV / EBITDA: 168.8x)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.